These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment. Guerra FM, Rosella LC, Dunn S, Wilson SE, Chen C, Deeks SL. Vaccine; 2016 Sep 07; 34(39):4678-4683. PubMed ID: 27527815 [Abstract] [Full Text] [Related]
5. The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada. Steben M, Ouhoummane N, Rodier C, Sinyavskaya L, Brassard P. J Med Virol; 2018 Mar 07; 90(3):592-598. PubMed ID: 28980715 [Abstract] [Full Text] [Related]
6. Health service utilisation for anogenital warts in Ontario, Canada prior to the human papillomavirus (HPV) vaccine programme introduction: a retrospective longitudinal population-based study. Guerra FM, Rosella LC, Dunn S, Wilson SE, Chen C, Deeks SL. BMJ Open; 2016 Mar 10; 6(3):e009914. PubMed ID: 26966057 [Abstract] [Full Text] [Related]
11. Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada. Righolt CH, Willows K, Kliewer EV, Mahmud SM. PLoS One; 2022 Mar 10; 17(4):e0267646. PubMed ID: 35472093 [Abstract] [Full Text] [Related]
14. Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada. Kliewer EV, Demers AA, Elliott L, Lotocki R, Butler JR, Brisson M. Sex Transm Dis; 2009 Jun 10; 36(6):380-6. PubMed ID: 19556932 [Abstract] [Full Text] [Related]
15. Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study. Mikolajczyk RT, Kraut AA, Horn J, Schulze-Rath R, Garbe E. Sex Transm Dis; 2013 Jan 10; 40(1):28-31. PubMed ID: 23250300 [Abstract] [Full Text] [Related]